VEGFA and diabetes mellitus: Our results suggest that inhibition of endogenous E2F1 may serve as an alternative approach to ensure continuous expression of VEGF in the wound and this is particularly useful for certain pathological conditions (e.g., diabetes), in which hypoxic response and VEGF induction are impaired [22].